Hexagon Capital Partners LLC Relmada Therapeutics, Inc. Transaction History
Hexagon Capital Partners LLC
- $546 Million
- Q4 2024
A detailed history of Hexagon Capital Partners LLC transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 4,000 shares of RLMD stock, worth $1,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$1,520
Previous $12,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RLMD
# of Institutions
55Shares Held
8.32MCall Options Held
364KPut Options Held
46.5K-
Franklin Resources Inc San Mateo, CA1.3MShares$494,8170.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.26MShares$477,5470.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.23MShares$466,6120.0% of portfolio
-
Black Rock Inc. New York, NY573KShares$217,8590.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA495KShares$188,1550.04% of portfolio
About RELMADA THERAPEUTICS, INC.
- Ticker RLMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,608,500
- Market Cap $10.9M
- Description
- Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...